Preparation of HCV NS3 and NS5B proteins to support small-molecule drug discovery

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 54, 2011, Pages

  Hung, Magdeleine ^a   Wang, Ruth ^a   Liu, Xiaohong ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

HCV; Helicase; Polymerase; Protease; Protein purification

Indexed keywords

HELICASE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5B; RECOMBINANT ENZYME; RNA DIRECTED RNA POLYMERASE; VIRUS FUSION PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; COLUMN CHROMATOGRAPHY; DRUG SCREENING; ENZYME PURIFICATION; HEPATITIS C VIRUS; ION EXCHANGE CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 84255201188     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/471141755.ph13b06s54     Document Type: Article

References (33)

1. Adachi, T., Ago, H., Habuka, N., Okuda, K., Komatsu, M., Ikeda, S., andYatusnami,K. 2003. The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNAdependent RNA polymerase. Biochem. Biophys. Acta 1601:38-48.
2. Bartenschlager, R., Lohmann, V., Wilkinson, T., and Koch, J.O. 1995. Complex formation between the NS3 serine-type proteinase of the Hepatitiis C virus and NS4A and its importance for polyprotein maturation. J. Virol. 69:7519-7528.
3. Behrens, S.E., Tomei, L., and De Francesco, R. 1996. Identification and properties of the RNAdependent RNApolymerase of hepatitis C virus. EMBO J. 15:12-22.
4. Beran, R.K.F. and Pyle, A.M. 2008. Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase. J. Biol. Chem. 283:29,929-29,937.
5. Beran, R.K.F., Serebrov, V., and Pyle, A.M. 2007. The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate. J. Biol. Chem. 282:34,913-34,920.
6. Choo, W.-L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., and Houghton, M. 1989. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359-362.
7. Choo, Q.-L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Meidna-Selby, A., Barr, P.J., Weiner, A.J., Bradley, D. W., Kuo, G., and Houghton, M. 1991. Genetic organization and diversity of the Hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88:2451-2455.
8. Ferrari, E., Wright-Minogue, J., Fang, J.W.S., Baroud, B.M., Lau, J.Y.N., and Hong, Z. 1999. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J. Virol. 73:1649-1654.
9. Frick, D.N., Rypma, R.S., Lam, A.M., and Gu, B. 2004. The nonstructural protein 3 protease/ helicase requires an intact protease domain to efficiently unwind duplex RNA. J. Biol. Chem. 279:1269-1280.
10. Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales Jr., F.L., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J., and Yu, J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
11. Gallinari, P., Brennan, D., Nardi, C., Brunetti, M., Tomei, L., Steinkuhler, C., and De Francesco, R. 1998. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J. Virol. 72:6758-6769.
12. Gallinari, P., Paolini, C., Brennan, D., Nardi, C., Steink̈uhler, C., and De Francesco, R. 1999. Modulation of hepatitis C Virus NS3 protease and helicase activities through the interaction with NS4A. Biochemistry 38:5620-5632.
13. Han, D.S., Hahm, B., Rho, H., and Jang, S.K. 1995. Identification of the protease domain in NS3 of hepatitis C virus. J. Gen. Virol. 76:985-993.
14. Hocek, M., Šilhár, P., Shih, I-H., Mabery, E., and Mackman, R. 2006. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: Synthesis and evaluation of 6-substituted purine L-ribonucleosides. Bioorg. Med. Chem. Lett. 16:5290-5293.
15. Kato, N., Hijikata, M., OOtsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T., and Shimotohno, K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87:9524-9528.
16. Kim, D.W., Gwack, Y., Han, J.H., and Choe, J. 1995. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Commun. 215:160-166.
17. Kim, J.L., Morgenstern, K.A., Lin, C., Fox, T., Dwyer, M.D., Landro, J.A., Chambers, S.P., Markland, W., Lepre, C.A., O'Malley, E.T., Harbeson, S.L., Rice, C.M., Murcko, M.A. Caron, P.R., and Thomson, J.A. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
18. Kuang, W.F., Lin, Y.C., Jean, F., Huang, Y.W., Tai, C.L., Chen, D.S., Chen, P.J., and Hwang, L.H. 2004. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A. Biochem. Biophys. Res. Commun. 317:211-217.
19. Lam, A.M. and Frick, D.N. 2006. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase. J. Virol. 80:404-411.
20. Landro, J.A., Raybuck, S.A., Luong, Y.P.C., O'Malley, E.T., Harbeson, S.L., Morgenstern, K.A., Rao,G., and Livingston, D.J. 1997. Mechanistic role of an NS4 peptide cofactor with the truncated NS3 protease of hepatitis C virus: Elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Biochemistry 36:9340-9348.
21. Lohmann, V., Koch, J.O., and Bartenschlager, R. 1996. Processing pathways of the hepatitis C virus proteins. J. Hepatol. 24:11-19.
22. Lohmann, V., Korner, F., Herian, U., and Bartenschlager, F. 1997. Biochemical properties of hepatitis C virus NS5b RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71:8416-8428.
23. Lohmann, V., Roos, A., Korner, F., Koch, J.O., and Bartenschlager, R., 1998. Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Virology 249:108-118.
24. Makrides, S.C. 1996. Strategies for achieving highlevel expression of genes in Escherichia coli. Microbiol. Rev. 60:512-538.
25. Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R.,Goodman, Z.D., Koury, K., Ling, M., and Albrecht, J.K. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial. Lancet 358:958-965.
26. Pang, P.S., Jankowsky, E., Planet, P.J., and Pyle, A.M. 2002. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J. 21:1168-1176.
27. Preugschat, F., Averett, D.R., Clarke, B.E., and Porter, J.T. 1996. A steady-state and pre-steadystate kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J. Biol. Chem. 271:24,449-24,457.
28. Suzich, J.A., Tamura, J.K., Palmer-Hill, F., Warrener, P., Grakoui, A., Rice, C.M., Feinstone, S.M., and Collett, M.S. 1993. Hepatitis C virus NS3 protein polynucleotidestimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67:6152-6158.
29. Taremi, S.S., Beyer, B.,Maher,M.,Yao, N., Prosise, W.,Weber, P.C., andMalcolm, B.A. 1998. Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease. Prot. Sci. 7:2143-2149.
30. Tomei, L., Vitale, R.L., Incitti, I., Serafini, S., Altamura, S., Vitelli, A., and De Francesco, R. 2000. Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence. J. Gen. Virol. 81:759-767.
31. Vermehren, J. and Sarrazin, C. 2011. New HCV therapies on the horizon. Clin.Microbiol. Infect. 17:122-134.
32. Yamashita, T., Kaneko, S., Shirota, Y., Qin, W., Nomura, T., Kobayashi, K., and Murakami, S. 1998. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5b protein truncated at the C-terminal region. J. Biol. Chem. 273:15,479-15,486.
33. Yan, Y., Li, Y., Munshi, S., Sardana, V., Cole, J.L. Sardana, M, Steink̈uhler, C., Tomei, L., De Francesco, R., Kue, L.C., and Chen, Z. 1998. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 A resolution structure in a hexagonal crystal form. Prot. Sci. 7:837-847.